BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 9053452)

  • 1. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus.
    Binder D; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Feb; 185(3):517-30. PubMed ID: 9053452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
    Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus.
    Leist TP; Aguet M; Hässig M; Pevear DC; Pfau CJ; Zinkernagel RM
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2213-8. PubMed ID: 3612089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta.
    Sandberg K; Kemper P; Stalder A; Zhang J; Hobbs MV; Whitton JL; Campbell IL
    J Immunol; 1994 Jul; 153(1):220-31. PubMed ID: 8207238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
    Bukowski JF; Biron CA; Welsh RM
    J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in gamma interferon-deficient mice infected with lymphocytic choriomeningitis virus.
    Bartholdy C; Christensen JP; Wodarz D; Thomsen AR
    J Virol; 2000 Nov; 74(22):10304-11. PubMed ID: 11044074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses.
    McNally JM; Zarozinski CC; Lin MY; Brehm MA; Chen HD; Welsh RM
    J Virol; 2001 Jul; 75(13):5965-76. PubMed ID: 11390598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction.
    Welsh RM
    J Exp Med; 1978 Jul; 148(1):163-81. PubMed ID: 307587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells.
    Ou R; Zhou S; Huang L; Moskophidis D
    J Virol; 2001 Sep; 75(18):8407-23. PubMed ID: 11507186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
    Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
    Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression.
    Fung-Leung WP; Kündig TM; Zinkernagel RM; Mak TW
    J Exp Med; 1991 Dec; 174(6):1425-9. PubMed ID: 1683893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection.
    Pien GC; Biron CA
    J Immunol; 2000 Jan; 164(2):994-1001. PubMed ID: 10623849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection.
    Mack EA; Kallal LE; Demers DA; Biron CA
    mBio; 2011; 2(4):. PubMed ID: 21828218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
    Le Bon A; Montoya M; Edwards MJ; Thompson C; Burke SA; Ashton M; Lo D; Tough DF; Borrow P
    Eur J Immunol; 2006 Aug; 36(8):2085-93. PubMed ID: 16810633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.